Daily Trades
- Dylan Jovine
Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
- Dylan Jovine
Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
- Dylan Jovine
It’s been a tough couple of weeks for markets. That’s been especially true of small-cap stocks.
- Dylan Jovine
On March 1st, we recommended Seagen (SYM: SGEN) at $179.90 a share.
- Dylan Jovine
I’m recommending shares of software maker New Relic, Inc (SYM: NEWR) here at $83.84 a share.
- Dylan Jovine
A lot of folks have asked my whether it’s time to take profits in Seagen (SYM: SGEN).
- Dylan Jovine
It’s been a tough week for markets. But the good news is that we started this week with a win.
- Dylan Jovine
Just a quick update this morning. Shares of Seagen, Inc (SYM: SGEN) were bought by Pfizer at $229 per share in cash.
- Dylan Jovine
I’m sending this out a day early. I’m recommending shares of Seagen, Inc (SYM: SGEN) here at $179.90 a share.
deal of the month
Categories
How I Got Into Biotech Stocks
My Journey Into Biotech Investing
Play it Safe & Take the Profits Off the Table
Recent posts
Tags
Connect with Us
- Dylan Jovine
Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
- Dylan Jovine
Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
- Dylan Jovine
It’s been a tough couple of weeks for markets. That’s been especially true of small-cap stocks.
- Dylan Jovine
On March 1st, we recommended Seagen (SYM: SGEN) at $179.90 a share.
- Dylan Jovine
I’m recommending shares of software maker New Relic, Inc (SYM: NEWR) here at $83.84 a share.
- Dylan Jovine
A lot of folks have asked my whether it’s time to take profits in Seagen (SYM: SGEN).
- Dylan Jovine
It’s been a tough week for markets. But the good news is that we started this week with a win.
- Dylan Jovine
Just a quick update this morning. Shares of Seagen, Inc (SYM: SGEN) were bought by Pfizer at $229 per share in cash.
- Dylan Jovine
I’m sending this out a day early. I’m recommending shares of Seagen, Inc (SYM: SGEN) here at $179.90 a share.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
